These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6272967

  • 1. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies.
    Purtilo DT, Sakamoto K, Saemundsen AK, Sullivan JL, Synnerholm AC, Anvret M, Pritchard J, Sloper C, Sieff C, Pincott J, Pachman L, Rich K, Cruzi F, Cornet JA, Collins R, Barnes N, Knight J, Sandstedt B, Klein G.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4226-36. PubMed ID: 6272967
    [Abstract] [Full Text] [Related]

  • 2. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
    Saemundsen AK, Purtilo DT, Sakamoto K, Sullivan JL, Synnerholm AC, Hanto D, Simmons R, Anvret M, Collins R, Klein G.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968
    [Abstract] [Full Text] [Related]

  • 3. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [Abstract] [Full Text] [Related]

  • 4. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
    Okano M.
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
    [Abstract] [Full Text] [Related]

  • 5. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG, Szigeti R, Ernberg I, Masucci G, Klein G, Chessels J, Sieff C, Lie S, Glomstein A, Businco L, Henle W, Henle G, Pearson G, Sakamoto K, Purtilo DT.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [Abstract] [Full Text] [Related]

  • 6. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
    Purtilo DT.
    AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus-induced diseases in the X-linked lymphoproliferative syndrome and related disorders.
    Purtilo DT.
    Biomed Pharmacother; 1985 Dec; 39(2):52-8. PubMed ID: 2990590
    [Abstract] [Full Text] [Related]

  • 8. [Epstein-Barr-virus-induced lymphoproliferative diseases].
    Schuster V, Kreth HW.
    Monatsschr Kinderheilkd; 1991 Jul; 139(7):396-400. PubMed ID: 1656248
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-associated lymphoproliferative disorders.
    Purtilo DT, Strobach RS, Okano M, Davis JR.
    Lab Invest; 1992 Jul; 67(1):5-23. PubMed ID: 1320711
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Abnormal anti-Epstein Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk.
    Sakamoto K, Seeley JK, Lindsten T, Sexton J, Yetz J, Ballow M, Purtilo DT.
    J Immunol; 1982 Feb; 128(2):904-7. PubMed ID: 6274962
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
    Mitarnun W, Suwiwat S, Pradutkanchana J, Saechan V, Ishida T, Takao S, Mori A.
    Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus and the X-linked lymphoproliferative syndrome.
    Sullivan JL.
    Adv Pediatr; 1983 May; 30():365-99. PubMed ID: 6324556
    [No Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus (EBV). VI. Incidence of EBV antibodies in patients with malignant lymphoproliferative diseases.
    Pătraşcu IV, Tache M, Stoia R, Berceanu S.
    Virologie; 1989 May; 40(1):31-4. PubMed ID: 2549700
    [Abstract] [Full Text] [Related]

  • 15. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, Bitker MO, Gandjbakhch I, Suberbielle C, Farcet JP.
    Transplantation; 1994 Aug 15; 58(3):317-24. PubMed ID: 8053055
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
    Klein G, Purtilo D.
    Cancer Res; 1981 Nov 15; 41(11 Pt 1):4302-4. PubMed ID: 6272974
    [No Abstract] [Full Text] [Related]

  • 19. The impact of EBV hybridization in clinical and biological medicine.
    Morinet F.
    Nouv Rev Fr Hematol (1978); 1989 Nov 15; 31(2):155-8. PubMed ID: 2549502
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M.
    Int J Oncol; 2004 May 15; 24(5):1165-74. PubMed ID: 15067338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.